within Pharmacolibrary.Drugs.N_NervousSystem.N06A_Antidepressants.N06AB10_Escitalopram;
model Escitalopram 
   extends Pharmacolibrary.Drugs.ATC.N.N06AB10;

  annotation(Documentation(
    info ="<html><body><p>Escitalopram is a selective serotonin reuptake inhibitor (SSRI) antidepressant used for the treatment of major depressive disorder, generalized anxiety disorder, social anxiety disorder, and panic disorder in adults. It is currently approved and widely used in clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers, both male and female.</p><h4>References</h4><ol><li><p>Rao, N (2007). The clinical pharmacokinetics of escitalopram. <i>Clinical pharmacokinetics</i> 46(4) 281–290. DOI:<a href=&quot;https://doi.org/10.2165/00003088-200746040-00002&quot;>10.2165/00003088-200746040-00002</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17375980/&quot;>https://pubmed.ncbi.nlm.nih.gov/17375980</a></p></li><li><p>Strawn, JR, et al., &amp; Croarkin, PE (2023). Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents. <i>Pharmacotherapy</i> 43(7) 675–690. DOI:<a href=&quot;https://doi.org/10.1002/phar.2767&quot;>10.1002/phar.2767</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36651686/&quot;>https://pubmed.ncbi.nlm.nih.gov/36651686</a></p></li><li><p>Burke, WJ (2002). Escitalopram. <i>Expert opinion on investigational drugs</i> 11(10) 1477–1486. DOI:<a href=&quot;https://doi.org/10.1517/13543784.11.10.1477&quot;>10.1517/13543784.11.10.1477</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12387707/&quot;>https://pubmed.ncbi.nlm.nih.gov/12387707</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Escitalopram;
